Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates

Ebola viruses cause hemorrhagic disease in humans and nonhuman primates with high fatality rates. These viruses pose a significant health concern worldwide due to the lack of approved therapeutics and vaccines as well as their potential misuse as bioterrorism agents. Although not licensed for human...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Marzi, Andrea, Engelmann, Flora, Feldmann, Friederike, Haberthur, Kristen, Shupert, W. Lesley, Brining, Douglas, Scott, Dana P., Geisbert, Thomas W., Kawaoka, Yoshihiro, Katze, Michael G., Feldmann, Heinz, Messaoudi, Ilhem
Format: Artigo
Langue:Inglês
Publié: National Academy of Sciences 2013
Sujets:
Biological Sciences
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3562844/
https://ncbi.nlm.nih.gov/pubmed/23319647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1209591110
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires